Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (311-320 of 340) with videos related to

Pageof 34
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer developmentJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Nature|April 12, 2023
Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagusJens Luebeck, Alvin Wei Tian Ng, Patricia C Galipeau, et al.
JCI Insight|July 13, 2021
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesionsJ Silvio Gutkind, Alfredo A Molinolo, Xingyu Wu, et al.
JAMA|June 7, 2006
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Cancer Research|December 4, 2012
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinomaPierre Saintigny, Erminia Massarelli, Steven Lin, et al.
Journal of the National Cancer Institute|April 13, 2011
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapyXifeng Wu, Yuanqing Ye, Rafael Rosell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 12, 2018
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public HealthScott M Lippman, Cory Abate-Shen, Karen L Colbert Maresso, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 34

Showing results (311-320 of 340) with videos related to

Sort By:
Pageof 34
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2015
New DNA methylation markers and global DNA hypomethylation are associated with oral cancer developmentJean-Philippe Foy, Curtis R Pickering, Vassiliki A Papadimitrakopoulou, et al.
Nature|April 12, 2023
Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagusJens Luebeck, Alvin Wei Tian Ng, Patricia C Galipeau, et al.
JCI Insight|July 13, 2021
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesionsJ Silvio Gutkind, Alfredo A Molinolo, Xingyu Wu, et al.
JAMA|June 7, 2006
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Cancer Research|December 4, 2012
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinomaPierre Saintigny, Erminia Massarelli, Steven Lin, et al.
Journal of the National Cancer Institute|April 13, 2011
Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapyXifeng Wu, Yuanqing Ye, Rafael Rosell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 12, 2018
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public HealthScott M Lippman, Cory Abate-Shen, Karen L Colbert Maresso, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 34